On the recordApril 19, 2023
The lack of face-to-face meetings may be negatively affecting the FDA's ability to keep pace and retain its scientific and regulatory stature as the gold standard.
Source
congress.govThe lack of face-to-face meetings may be negatively affecting the FDA's ability to keep pace and retain its scientific and regulatory stature as the gold standard.
Concerned about the impact of remote communication on FDA's effectiveness.
Share
More from Susan Collins
“I believe that all of us must avoid that kind of dangerous and disturbing rhetoric, because it could in fact trigger violence,” Collins added.